|
Originally published In Press as doi:10.1074/jbc.M310804200 on November 18, 2003
J. Biol. Chem., Vol. 279, Issue 8, 7029-7036, February 20, 2004
cAMP-dependent Protein Kinase Regulatory Subunit Type II
ACTIVE SITE MUTATIONS DEFINE AN ISOFORM-SPECIFIC NETWORK FOR ALLOSTERIC SIGNALING BY cAMP*
Kerri M. Zawadzki and
Susan S. Taylor ¶||
From the
Department of Chemistry and Biochemistry and the ¶Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California 92093-0654
cAMP-dependent protein kinase (cAPK) contains a regulatory (R) subunit dimer bound to two catalytic (C) subunits. Each R monomer contains two cAMP-binding domains, designated A and B. The sequential binding of two cAMPs releases active C. We describe here the properties of RII and two mutant RII subunits, engineered by converting a conserved Arg to Lys in each cAMP-binding domain thereby yielding a protein that contains one intact, high affinity cAMP-binding site and one defective site. Structure and function were characterized by circular dichroism, steady-state fluorescence, surface plasmon resonance and holoenzyme activation assays. The Ka for RII is 610 nM, which is 10-fold greater than its Kd(cAMP) and significantly higher than for RI and RII . The Arg mutant proteins demonstrate that the conserved Arg is important for both cAMP binding and organization of each domain and that binding to domain A is required for activation. The Ka of the A domain mutant protein is 21-fold greater than that of wild-type and the Kd(cAMP) is increased 7-fold, confirming that cAMP must bind to the mutated site to initiate activation. The domain B mutant Ka is 2-fold less than its Kd(cAMP), demonstrating that, unlike RI , cAMP can access the A site even when the B site is empty. Removal of the B domain yields a Ka identical to the Kd(cAMP) of full-length RII , indicating that the B domain inhibits holoenzyme activation for RII . In RI , removal of the B domain generates a protein that is more difficult to activate than the wild-type protein.
Received for publication, October 1, 2003
* This work was supported in part by National Institutes of Health (NIH) Grant GM34921 (to S. S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Department of Education Graduate Assistance in Areas of National Need (GAANN) Fellowship and NIH Training Grant GM08326-10.
|| To whom correspondence should be addressed. Tel.: 858-534-5554; Fax: 858-534-8193; E-mail: staylor{at}ucsd.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|